简介：
Overview
This protocol demonstrates an algorithm for testing the efficacy of targeted therapies based on the genomic makeup of tumors. It includes the identification of structural DNA rearrangements and the engraftment of patient tumors into mice for drug response testing.
Key Study Components
Area of Science
- Oncology
- Genomics
- Pharmacology
Background
- Targeted therapies are selected based on genomic alterations.
- Understanding DNA rearrangements can inform treatment options.
- In vivo models are essential for testing drug efficacy.
- Immunocompromised mice are used for tumor engraftment.
Purpose of Study
- To validate the efficacy of drugs selected through genomic analysis.
- To establish a protocol for in vivo testing of targeted therapies.
- To enhance understanding of tumor responses to specific treatments.
Methods Used
- Whole genome bio-sequencing of human tumor specimens.
- Identification of genomic alterations, including gene rearrangements.
- Selection of potentially druggable changes based on analysis.
- In vivo treatment of tumors in immunocompromised mice.
Main Results
- Successful identification of structural DNA rearrangements.
- Validation of selected drugs in mouse models.
- Demonstration of treatment efficacy based on genomic analysis.
- Insights into tumor behavior in response to targeted therapies.
Conclusions
- The protocol provides a framework for testing targeted therapies.
- Genomic analysis is crucial for selecting effective treatments.
- In vivo models are valuable for understanding drug responses.
What is the main focus of this protocol?
The protocol focuses on testing the efficacy of targeted therapies based on genomic alterations in tumors.
How are genomic alterations identified?
Genomic alterations are identified through whole genome bio-sequencing of human tumor specimens.
What type of animal models are used?
Immunocompromised mice are used for engrafting patient tumors.
What is the significance of structural DNA rearrangements?
Structural DNA rearrangements can indicate potential druggable targets for therapy.
How does this study contribute to cancer treatment?
It provides a systematic approach to selecting and testing targeted therapies based on genomic data.
What are the expected outcomes of the treatment?
The expected outcomes include improved understanding of tumor responses and validation of effective therapies.
繁體中文
